OpenAlex
PricingAboutJobs
Log inGet started
Work

Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations

HTML

Year: 2017
Type: article
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-16-3250
Authors: Yung-mae M. Yao, Gregory P. Donoho, Philip W. Iversen, Youyan Zhang, Robert D. Van Horn, Amelie Forest, Ruslan D. Novosiadly, Yue Wang Webster, Philip Ebert, Steven Bray, Jason C. Ting, Amit Aggarwal, James R. Henry, Ramon V. Tiu, Gregory D. Plowman, Sheng-Bin Peng
Institution: Eli Lilly (United States)
Language: English

Topic: Colorectal Cancer Treatments and Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: colorectal cancer, cetuximab, LY3009120, EGFR inhibition, BRAF mutation, KRAS mutation, patient-derived xenografts, combination therapy, drug synergy, MAPK signaling, drug resistance
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2625195938
FWCI: 2.425
Cites: 52
Cited by: 47
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security